Position in SGMT
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$78,375
-$10,425 QoQ
Shares Held
15,000
0.0% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SGMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 20261492 Capital Management LLC holds $15,660,741 across 10 Biotechnology names. SGMT ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KURA |
Kura Oncology, Inc.
|
486,123 | $3,952,179 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
18,594 | $3,142,757 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
118,156 | $2,783,755 | |
| 4 | MNKD |
Mannkind Corp
|
549,782 | $1,346,965 | |
| 5 | VKTX |
Viking Therapeutics, Inc.
|
41,181 | $1,340,029 | |
| 6 | DNLI |
Denali Therapeutics Inc.
|
67,417 | $1,294,406 | |
| 7 | ADMA |
Adma Biologics, Inc.
|
113,155 | $1,019,526 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,958 | $390,914 |
All Filings in SGMT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $78,375 | 15,000 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $88,800 | 15,000 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $102,900 | 15,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||